- Home
- RELX vs ORMP Comparison
RELX vs ORMP Comparison
Compare RELX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RELX | ORMP |
|---|---|---|
| Founded | 1903 | 2002 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.0B | 170.3M |
| IPO Year | 2007 | 2010 |
Fundamental Metrics
Financial Performance| Metric | RELX | ORMP |
|---|---|---|
| Price | $33.80 | $4.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 218.9K |
| Earning Date | 02-12-2026 | 05-14-2026 |
| Dividend Yield | 2.42% | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | $8.72 | N/A |
| Revenue Next Year | $6.41 | N/A |
| P/E Ratio | $20.27 | ★ $1.73 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $27.57 | $2.09 |
| 52 Week High | $48.40 | $5.47 |
Technical Indicators
Market Signals| Indicator | RELX | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 50.75 |
| Support Level | $33.24 | $3.91 |
| Resistance Level | $34.19 | $5.10 |
| Average True Range (ATR) | 0.57 | 0.24 |
| MACD | -0.27 | -0.04 |
| Stochastic Oscillator | 0.31 | 13.58 |
Price Performance
Historical ComparisonAbout RELX RELX PLC PLC
RELX is a developer of information-based analytics and decision tools designed to support research, risk assessment, legal work, and business operations. The company offers data analytics, scientific and technical information resources, legal research tools, and event management platforms. This enables professionals, researchers, legal teams, and businesses to make informed decisions and improve operational efficiency.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.